Literature DB >> 3837956

Effect of in vitro ketoconazole on steroid production in rat testis.

J Rajfer, S C Sikka, H W Xie, R S Swerdloff.   

Abstract

In an attempt to confirm where in the testosterone (T) biosynthetic pathway of the rat testis ketoconazole (KTZ) inhibits T production, rat testicular mince was incubated with either 10 micrograms/ml or 100 micrograms/ml KTZ in the presence and absence of hCG (1 IU), and intratesticular pregnenolone (delta 5P), progesterone (P), 17-alpha-hydroxyprogesterone (17 alpha-HP), androstenedione (A) and testosterone (T) were assayed. In the absence of hCG, 10 micrograms/ml KTZ was sufficient to reduce intratesticular T by 80%. At this concentration of KTZ, intratesticular 17 alpha-HP (ng/g testis, mean +/- SEM) increased from 0.3 +/- 0.1 to 1.3 +/- 0.2 (p less than 0.0025), whereas intratesticular A decreased from 84 +/- 7 to 17 +/- 1 (p less than 0.005). KTZ did not inhibit the conversion of P to 17 alpha-HP. From these data it was concluded that KTZ has its inhibitory effect on testosterone biosynthesis in the rat testis primarily at the step catalyzed by the 17,20 desmolase enzyme.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3837956     DOI: 10.1016/0039-128x(85)90035-2

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  3 in total

1.  Humanin protects against chemotherapy-induced stage-specific male germ cell apoptosis in rats.

Authors:  P Surampudi; I Chang; Y Lue; T Doumit; Y Jia; V Atienza; P Y Liu; R S Swerdloff; C Wang
Journal:  Andrology       Date:  2015-04-16       Impact factor: 3.842

2.  Fluconazole and testosterone: in vivo and in vitro studies.

Authors:  D P Hanger; S Jevons; J T Shaw
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

3.  Selective inhibition of steroidogenic enzymes by ketoconazole in rat ovary cells.

Authors:  Michael Gal; Joseph Orly
Journal:  Clin Med Insights Reprod Health       Date:  2014-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.